YAP/STAT3 promotes the immune escape of larynx carcinoma by activating VEGFR1-TGFβ signaling to facilitate PD-L1 expression in M2-like TAMs Xiao-Xiao Du et al, 2021, Experimental Cell Research CrossRef
Dihydroartemisinin as a Putative STAT3 Inhibitor, Suppresses the Growth of Head and Neck Squamous Cell Carcinoma by Targeting Jak2/STAT3 Signaling Lifeng Jia et al, 2016, PLOS ONE CrossRef
PAG1 promotes the inherent radioresistance of laryngeal cancer cells via activation of STAT3 Li Shen et al, 2018, Experimental Cell Research CrossRef
STAT3: A Novel Molecular Mediator of Resistance to Chemoradiotherapy Melanie Spitzner et al, 2014, Cancers CrossRef
Oligonucleotide-Based Therapeutics for STAT3 Targeting in Cancer—Drug Carriers Matter Sara Molenda et al, 2023, Cancers CrossRef
Systemic brain tumor delivery of synthetic protein nanoparticles for glioblastoma therapy Jason V. Gregory et al, 2020, Nature Communications CrossRef
MSCs inhibit tumor progression and enhance radiosensitivity of breast cancer cells by down-regulating Stat3 signaling pathway Ningning He et al, 2018, Cell Death & Disease CrossRef
Gold Nanoparticles as Radiosensitizers in Cancer Radiotherapy
Yao Chen et al, 2020, International Journal of Nanomedicine CrossRef
Signal transducer and activator of transcription 3 in myeloid-derived suppressor cells: an opportunity for cancer therapy Inès Dufait et al, 2106, Oncotarget CrossRef
The association of changes in RAD51 and survivin expression levels with the proton beam sensitivity of Capan‑1 and Panc‑1 human pancreatic cancer cells Min‑Gu Lee et al, 2018, International Journal of Oncology CrossRef
STAT3, the Challenge for Chemotherapeutic and Radiotherapeutic Efficacy Ping-Lian Yang et al, 2020, Cancers CrossRef
Suppression of autophagy augments the radiosensitizing effects of STAT3 inhibition on human glioma cells Xiaopeng Yuan et al, 2015, Experimental Cell Research CrossRef